Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scharrer

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Der Orthopade|March 2, 2017
Diagnosis and therapy of coagulation disorders in operative orthopedicsI Scharrer
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 1, 1999
Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiencyI Scharrer
Hamostaseologie|March 19, 2004
Women with von Willebrand diseaseI Scharrer
Annals of Hematology|September 1, 1991
Current status of a recombinant antihemophilic factor VIII clinical trial organized by BaxterI Scharrer
Die Medizinische Welt|July 9, 1976
[How does acetylsalicylic acid act as an aggregation inhibitor?]I Scharrer
Der Orthopade|May 21, 1999
[Diagnosis and management of coagulation disorders in orthopedic surgery]I Scharrer
Blut|September 1, 1983
The von Willebrand-syndromeI Scharrer
Der Radiologe|November 1, 1971
[Therapy of thromboembolic processes using acetylsalicylic acid. Action mechanism and clinical aspects]I Scharrer
Hamostaseologie|June 1, 2005
[Haemostaseological diseases on the intensive care units: TTP, HUS, spontaneous acquired FVIII inhibitor haemophilia and catastrophic antiphospholipid syndrome]I Scharrer
Hamostaseologie|June 1, 2005
[Liver cirrhosis and coagulopathy]I Scharrer
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Der Orthopade|March 2, 2017
Diagnosis and therapy of coagulation disorders in operative orthopedicsI Scharrer
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 1, 1999
Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiencyI Scharrer
Hamostaseologie|March 19, 2004
Women with von Willebrand diseaseI Scharrer
Annals of Hematology|September 1, 1991
Current status of a recombinant antihemophilic factor VIII clinical trial organized by BaxterI Scharrer
Die Medizinische Welt|July 9, 1976
[How does acetylsalicylic acid act as an aggregation inhibitor?]I Scharrer
Der Orthopade|May 21, 1999
[Diagnosis and management of coagulation disorders in orthopedic surgery]I Scharrer
Blut|September 1, 1983
The von Willebrand-syndromeI Scharrer
Der Radiologe|November 1, 1971
[Therapy of thromboembolic processes using acetylsalicylic acid. Action mechanism and clinical aspects]I Scharrer
Hamostaseologie|June 1, 2005
[Haemostaseological diseases on the intensive care units: TTP, HUS, spontaneous acquired FVIII inhibitor haemophilia and catastrophic antiphospholipid syndrome]I Scharrer
Hamostaseologie|June 1, 2005
[Liver cirrhosis and coagulopathy]I Scharrer
Pageof 18